C1q: Its functions within the innate and adaptive immune responses and its role in lupus autoimmunity

Journal of Investigative Dermatology

Volumn 125, Issue 1, 2005, Pages 14-23

  Sontheimer, Richard D ^a,b   Racila, Emil ^a   Racila, Doina M ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

C1q; Innate immune response; Subacute cutaneous lupus erythematosus (SCLE); Systemic lupus erythematosus (SLE)

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ACUTE PHASE RESPONSE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 22144470162     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23673.x     Document Type: Article

References (60)

1. Arlaud GJ, Gaboriaud C, Thielens NM, Budayova-Spano M, Rossi V, Fontecilla-Camps JC: Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol Immunol 39:383-394, 2002
2. Baima B, Sticherling M: Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 144:958-966, 2001
3. Barilla-LaBarca ML, Atkinson JP: Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55-60, 2003
4. Berner B, Sheel AK, Schettler V, Hummell KM, Reuss-Borst KM, Muller GA: Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis p 898-899, 2001
5. Bradley AJ, Brooks DE, Norris-Jones R, Devine DV: C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Biochim Biophys Acta 1418:19-30, 1999
6. Carroll MC: A protective role for innate immunity in autoimmune disease. Clin Immunol 95:330-338, 2000
7. Castellano G, Woltman AM, Nauta AJ, et al: Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 103:3813-3820, 2004
8. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EI, Ghebrehiwet B: Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol 153:1430-1440, 1994a
9. Chen A, Gaddipati S, Hong Y, Volkman DJ, Peerschke EIB, Ghebrehiwet B: Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation. J Immunol 153:1430-1440, 1994b
10. Chen XG, Smith JD, Shi H, et al: The Ro autoantigen binds misfolded U2 small nuclear RNAs and assists mammalian cell survival after UV irradiation Topical tacrolimus in the treatment of localized scleroderma. Curr Biol 13:2206-2211, 2003
11. Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD: Calreticulin binds hYRNA and the 52 KD polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol 156:4484-4491, 1996
12. Chung JH, Kwon OS, Eun HC, Youn JI, Song YW, Kim JG, Cho KH: Apoptosis in the pathogenesis of cutaneous lupus erythematosus. Am J Dermatopathol 20:233-241, 1998
13. Eggleton P, Ghebrehiwet B, Sastry KN, Coburn JP, Zaner KS, Reid KB, Tauber AI: Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R. J Clin Invest 95:1569-1578, 1995
14. Eggleton P, Michalak M (eds). Calreticulin, 2nd edn. Austin: Landes Press, 2003
15. Fadeel B and bengt.fadeel@imm.ki.se Programmed cell clearance [Review]. Cell Mol. Life Sci 60:2575-2585, 2003
16. Francis K, van Beek J, Canova C, Neal JW, Gasque P: Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med May 23: 1-9, 2003
17. Gaboriaud C, Juanhuix J, Gruez A, et al: The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem 278:46974-46982, 2003
18. Ghebrehiwet B, Feng X, Kumar R, Peerschke EI: Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and integrins. Immunobiology 3:299-310, 2003
19. Ghebrehiwet B, Peerschke EI: Role of C1q and C1q receptors in the pathogenesis of systemic lupus erythematosus. Curr Dir Autoimmun 7:87-97, 2004
20. Ghiran I, Tyagi SR, Klickstein LB, Nicholson-Weller A: Expression and function of C1q receptors and C1q binding proteins at the cell surface. Immunobiology 205:407-420, 2002
21. Hoekzema R, Hannema AJ, Swaak TJ, Paardekooper J, Hack CE: Low molecular weight C1q in systemic lupus erythematosus. J Immunol 135:265-271, 1985
22. Jiang HX, Siegel JN, Gewurz H: Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J Immunol 146:2324-2330, 1991
23. Jiang K, Chen Y, Xu CS, Jarvis JN: T cell activation by soluble C1q-bearing immune complexes: Implications for the pathogenesis of rheumatoid arthritis. Clin Exp Immunol 131:61-67, 2003
24. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB: Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 987:68-78, 2003
25. Kishore U, Sontheimer RD, Sastry KN, et al: Release of calreticulin from neutrophils may alter C1q-mediated immune functions. Biochem J 322: 543-550, 1997a
26. Kishore U, Sontheimer RD, Sastry KN, et al: The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q-association with immune complexes. Clin Exp Immunol 108:181-190, 1997b
27. Kojouharova MS, Tsacheva IG, Tchorbadjieva MI, Reid KBM, Kishore U: Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies. Biochem Biophys Acta 1652:64-74, 2003
28. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes-complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525-4528, 1997
29. Kovacs H, Campbell ID, Strong P, Johnson S, Ward FJ, Reid KB, Eggleton P: Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation. Biochemistry 37:17865-17874, 1998
30. Lauber K, Bohn E, Krober SM, et al: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717-730, 2003
31. Leigh LE, Ghebrehiwet B, Perera TP, et al: C1q-mediated chemotaxis by human neutrophils: Involvement of gC1qR and G-protein signalling mechanisms. Biochem J 330 (Pt 1):247-254, 1998
32. Lieu TS, Sontheimer RD: A subpopulation of Wil-2 Cell calreticulin molecules is associated with Ro/SS-A ribonucleoprotein particles. Lupus 6:40-47, 1997
33. Lu KQ, Brenneman S, Burns R, Vink A, Gaines E, Haake A, Gaspari A and agasp001@umaryland.edu: Thalidomide inhibits UVB-induced mouse keratinocyte apoptosis by both TNF-alpha-dependent and TNF-alpha-independent pathways. Photodermatol Photoimmunol Photomed 19:272-280, 2003
34. Manderson AP, Botto M, Walport MJ: The role of complement in the development of systemic lupus erythematosus. Annu Rev immunol 22:431-456, 2004
35. McCauliffe DP, Zappi E, Lieu T-S, Michalak M, Sontheimer RD, Capra JD; A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule". J Clin Invest 86:332-335, 1990
36. Miura-Shimura Y, Nakamura K, Ohtsuji M, et al: C1q regulatory region polymorphism down-regulating murine C1q protein levels with linkage to lupus nephritis. Ann Dermatol Venereol 169:1334-1339, 2002
37. Miwa T, Maldonado MA, Zhou L, et al: Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol 161:1077-1086, 2002
38. Morgan BP, Harris CL: Complement Regulatory Proteins. San Diego: Academic Press, 1999
39. Nash JT, Taylor PR, Botto M, Norsworthy PJ, Davies KA, Walport MJ: Immune complex processing in C1q-deficient mice. Clin Exp Immunol 123: 196-202, 2001
40. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM: The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166:3231-3239, 2001
41. Norsworthy PJ, Fossati-Jimack L, Cortes-Hernandez J, et al: Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. J Immunol 172:3406-3414, 2004
42. O'Brien CA, Wolin SL: A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. Genes Dev 8:2891-2903, 1994
43. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM: C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194:781-795, 2001
44. Pablos JL, Santiago B, Galindo M, Carreira PE, Ballestin C, Gomez-Reino JJ: Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis. J Pathol 188:63-68, 1999
45. Pfueller B, Wolbart K, Bruns A, Burmester GR, Hiepe F: Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: A pilot study. Arthritis Rheum 44:1962-1963, 2001
46. Pickering MC, Fischer S, Lewis MR, Walport MJ, Botto M, Cook HT: Ultraviolet-radiation-induced keratinocyte apoptosis in C1q-deficient mice. J Invest Dermatol 117:52-58, 2001
47. Racila D, Sontheimer RD: C1q inhibits autoantibody binding to calreticulin. Lupus 8:300-304, 1999
48. Racila DM, Sontheimer CJ, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD: Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 12:124-132, 2003
49. Sontheimer RD, Racila D, Racila E, Eggleton P, Donnelly S: Calreticulin's role(s) in autoimmune disorders. In: Michalek M, Eggleton P (eds) Calreticulin. New York: Landes Bioscience & Kluwer Academic Press, 2003; p 180-192
50. Steino A, Jorgensen CS, Laursen I, Houen G: Interaction of c1q with the receptor calreticulin requires a conformational change in C1q. Scand J Immunol 59:485-495, 2004
51. Toomayan GA, Chen LE, Jiang HX, Qi WN, Seaber AV, Frank MM, Urbaniak JR: C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle. Microsurgery 23:561-567, 2003
52. Topaloglu R, Bakkaloglu A, Slingsby JH, Aydintug O, Besbas N, Saatci U, Walport MJ: Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency. Clin Exp Rheumatol 18:75-77, 2000
53. van de Wetering JK, van Golde LM, Batenburg JJ: Collectins: Players of the innate immune system. Eur J Biochem 271:1229-1249, 2004
54. van den Berg RH, Faber-Krol MC, van de Klundert JA, Van Es LA, Daha MR: Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol 156:4466-4473, 1996
55. van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, Van Es LA, Daha MR: Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 111:359-364, 1998
56. Vandivier RW, Ogden CA, Fadok VA, et al: Role of surfactant proteins A, D, and C1q in the clearance of apoptottc cells in vivo and in vitro: Calreticulin and CD91 as a common collectin receptor complex. J Immunol 169: 3978-3986, 2002
57. Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B: Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells Immunobiology 3:345-357, 2003
58. Whaley K, Ahmed AE: Control of immune complexes by the classical pathway. Behring Inst Mitt 84:111-120, 1989
59. Xue D, Shi H, Smith JD, et al: A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci USA 100:7503-7508, 2003
60. Yamada M, Oritani K, Kaisho T, et al: Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol 34:221-230, 2004